Top 5 Healthcare Stocks the Experts at Sphera Global Healthcare Fund Are Buying

3. Eli Lilly and Company (NYSE:LLY)

Topping the list is Eli Lilly and Company (NYSE:LLY), which ranks as Sphera Global’s top stock pick as of September 30. It’s also a company the fund was buying more shares of during the third quarter, 166,600 when all was said and done. That gives Sphera Global 348,495 LLY shares valued at $80.52 million on September 30. Hedge funds have never been more bullish on Eli Lilly and Company (NYSE:LLY) and have cashed in mightily on the stock as shares doubled between Q3 2019 and Q3 2021.

Eli Lilly and Company (NYSE:LLY) also has a growing legion of fans outside the hedge fund world, with the company ranking as one of Jim Cramer’s Top 10 Stock Picks for 2022. Cramer likes the earnings potential of Eli Lilly’s Alzheimer’s and diabetes drugs, which the company discussed during its December investor presentation. The company is also bullish on the uptake of its key growth products, predicting 2022 EPS of $8.50 to $8.65, well ahead of the consensus estimate of $7.30.